Assignee
FIVE ELEVEN PHARMA INC
US·5 granted patents·3 pending applications·17 citations·filing 2016–2021
Top patents by PatentIndex Score
8 records- 0188US10912849B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2018·Granted Feb 9, 2021·6 cites·16 claims
- 0288US10688200B2Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapyFIVE ELEVEN PHARMA INC·Filed 2016·Granted Jun 23, 2020·8 cites·22 claims
- 0381US11071794B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2020·Granted Jul 27, 2021·2 cites·13 claims
- 0472US12544463B2Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological applicationFIVE ELEVEN PHARMA INC·Filed 2021·Granted Feb 10, 2026·0 cites·11 claims
- 0564US10253052B2HBED-bisphosphonates, radiometal conjugates and their use as theranostic agentsFIVE ELEVEN PHARMA INC·Filed 2016·Granted Apr 9, 2019·1 cites·28 claims
- 0649US2024158420A1[18f]a1f labeled psma targeting molecular probe and preparation method thereforFIVE ELEVEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0749US2024139350A1Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method thereforFIVE ELEVEN PHARMA INC·Filed 2021·Application pending·0 cites
- 0846US2022125959A1Prostate-specific membrane antigen (psma) inhibitors as diagnostic and radionuclide therapeutic agentsFIVE ELEVEN PHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FIVE ELEVEN PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →